Patents by Inventor Paul R. Jensen

Paul R. Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salinamides
    Patent number: 5688783
    Abstract: Salinamides A and B are disclosed. These two bicyclic depsipeptides are produced by fermentation of a specific marine actinomycete, a Streptomyces sp, (CNB-091) in saltwater-based media. Salinamides A and B are useful as anti-biotic and anti-inflammatory agents.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: November 18, 1997
    Assignee: The Regents of the University of California
    Inventors: William H. Fenical, Robert S. Jacobs, Paul R. Jensen
  • Cyclic heptapeptide anti-inflammatory agent
    Patent number: 5593960
    Abstract: A cyclic heptapeptide anti-inflammatory agent named cyclomarin-A is disclosed. Cyclomarin-A is produced by a specific marine actinomycete. The cyclomarin-A producing bacterium is isolated from sediment located in marine estuaries in and around San Diego, Calif. Fermentation of the isolated bacterium in saltwater-based media produces cyclomarin-A as a secondary by-product. The cyclomarin-A is useful as an anti-inflammatory agent.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: January 14, 1997
    Assignee: The Regents of the University of California
    Inventors: William H. Fenical, Robert S. Jacobs, Paul R. Jensen
  • Eleutherobin and analogs thereof
    Patent number: 5473057
    Abstract: Eleutherobin is a glycosylated diterpene which has the structural formula: ##STR1## Eleutherobin is a cytotoxic agent which is toxic to carcinoma cancer cells. Analogs of eleutherobin are also disclosed.
    Type: Grant
    Filed: November 9, 1994
    Date of Patent: December 5, 1995
    Assignee: The Regents of the University of California
    Inventors: William H. Fenical, Paul R. Jensen, Thomas Lindel
  • Cyclic heptapeptide anti-inflammatory agent
    Patent number: 5444043
    Abstract: A cyclic heptapeptide anti-inflammatory agent named cyclomarin-A is disclosed.Cyclomarin-A is produced by a specific marine actinomycete. The cyclomarin-A producing bacterium is isolated from sediment located in marine estuaries in and around San Diego, Calif. Fermentation of the isolated bacterium in saltwater-based media produces cyclomarin-A as a secondary by-product. The cyclomarin-A is useful as an anti-inflammatory agent.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: August 22, 1995
    Assignee: The Regents of the University of California
    Inventors: William H. Fenical, Robert S. Jacobs, Paul R. Jensen